Vigilare Wealth Management Marker Therapeutics, Inc. Transaction History

Vigilare Wealth Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 07, 2022	SELL	$0.95 - $1.72 $97,375 - $176,300	-102,500 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$1.68 - $2.88 $13,440 - $23,040	-8,000 Reduced 7.24%	102,500 $173,000
Q2 2021 Jul 16, 2021	SELL	$1.88 - $3.56 $32,147 - $60,876	-17,100 Reduced 13.4%	110,500 $308,000
Q1 2021 Apr 29, 2021	SELL	$1.47 - $3.29 $20,800 - $46,553	-14,150 Reduced 9.98%	127,600 $286,000
Q4 2020 Jan 14, 2021	BUY	$1.36 - $1.75 $18,088 - $23,275	13,300 Added 10.35%	141,750 $206,000

Q3 2020 Oct 15, 2020	BUY	$1.5 - $2.2 $37,500 - $55,000	25,000 Added 24.17%	128,450 $193,000
Q2 2020 Jul 20, 2020	SELL	$1.69 - $2.79 $85,184 - $140,629	-50,405 Reduced 32.76%	103,450 $214,000
Q1 2020 May 04, 2020	BUY	$1.59 - $3.35 $57,327 - $120,784	36,055 Added 30.61%	153,855 $292,000
Q4 2019 Feb 13, 2020	BUY	$2.68 - $4.85 $315,704 - $571,330	117,800 New	117,800 $306,000

472K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $415M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.